AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...
Learn everything you need to know about Amplify Seymour Cannabis ETF (CNBS) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the ...
Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback